Rhea N Coler
Overview
Explore the profile of Rhea N Coler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
6371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bel Hadj Ali I, Saadi-Ben Aoun Y, Khammeri I, Souguir H, Harigua-Souiai E, Chouaieb H, et al.
Front Microbiol
. 2025 Feb;
15:1514684.
PMID: 39931278
Introduction: Cutaneous leishmaniases (CL), a wide range of cutaneous diseases caused by diverse species of genus parasites, are among the most neglected infectious diseases. While they are non-fatal, CL are...
2.
Abdelaal H, Berube B, Podell B, Harband M, Gary H, Perez-Jaimes M, et al.
NPJ Antimicrob Resist
. 2025 Jan;
2(1):49.
PMID: 39843983
Tuberculosis (TB) killed approximately 1.3 million people in 2022 and remains a leading cause of death from the bacteria Mycobacterium tuberculosis (M.tb); this number of deaths was surpassed only by...
3.
Smytheman T, Pecor T, Miller D, Ferede D, Kaur S, Harband M, et al.
Virol J
. 2025 Jan;
22(1):14.
PMID: 39833928
For much of the last decade, tuberculosis (TB) was the leading cause of mortality due to an infectious pathogen (Mycobacterium tuberculosis, M.tb). Approximately 1.3 million deaths in 2023 worldwide were...
4.
Lyu J, Narum D, Baldwin S, Larsen S, Bai X, Griffith D, et al.
Front Immunol
. 2024 Dec;
15:1427559.
PMID: 39717773
Granulomas, organized aggregates of immune cells which form in response to (), are characteristic but not exclusive of tuberculosis (TB). Despite existing investigations on TB granulomas, the determinants that differentiate...
5.
Painter H, Larsen S, Williams B, Abdelaal H, Baldwin S, Fletcher H, et al.
mSphere
. 2024 Dec;
10(1):e0086424.
PMID: 39651886
Importance: Understanding the strengths or limitations of back-translating human-derived correlate of risk (COR) RNA signatures into the preclinical pipeline may help streamline down-selection of therapeutic vaccine and drug candidates and...
6.
Rubino I, Guerrero-Bustamante C, Harrison M, Co S, Tetreau I, Ordoubadi M, et al.
bioRxiv
. 2024 Nov;
PMID: 39554140
The global tuberculosis (TB) epidemic affected 10 million people and caused 1.3 million deaths in 2022 alone. Multidrug-resistant TB is successfully treated in less than 60% of cases by long,...
7.
Larsen S, Abdelaal H, Plumlee C, Cohen S, Kim H, Barrett H, et al.
Front Immunol
. 2024 Nov;
15:1427510.
PMID: 39530100
The three programs that make up the Immune Mechanisms of Protection Against Centers (IMPAc-TB) had to prioritize and select strains to be leveraged for this work. The CASCADE team based...
8.
Wang Q, Nag D, Baldwin S, Coler R, McNamara R
Front Immunol
. 2024 Sep;
15:1430955.
PMID: 39286260
Tuberculosis (TB) is caused by infection with the bacterial pathogen (M.tb) in the respiratory tract. There was an estimated 10.6 million people newly diagnosed with TB, and there were approximately...
9.
Williams B, Ferede D, Abdelaal H, Berube B, Podell B, Larsen S, et al.
Front Immunol
. 2024 Jul;
15:1424374.
PMID: 38966641
At the beginning of the COVID-19 pandemic those with underlying chronic lung conditions, including tuberculosis (TB), were hypothesized to be at higher risk of severe COVID-19 disease. However, there is...
10.
Painter H, Larsen S, Williams B, Abdelaal H, Baldwin S, Fletcher H, et al.
bioRxiv
. 2024 Jul;
PMID: 38948876
One Sentence Summary: Human-derived biosignatures of tuberculosis disease progression were evaluated for their predictive fidelity across preclinical species and derived tissues using available public data sets.